Today: 2 February 2026
Subscribe
Browse Category

Biotechnology News 22 June 2025

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Pfizer Inc., in collaboration with BioNTech, co-developed the first FDA-approved mRNA COVID-19 vaccine, Comirnaty. Roche Holding AG is the world’s largest biotech company and a leader in oncology treatments (Herceptin) and diagnostics. Moderna, Inc. pioneered mRNA vaccine technology and its COVID-19 vaccine was among the first mRNA medicines approved, while expanding mRNA therapeutics for cancer and rare diseases. Illumina, Inc.…
22 June 2025
·
1 … 23 24 25

Stock Market Today

  • Meta Platforms Shares Show 31% Undervaluation Despite 3-Year Surge
    February 2, 2026, 3:11 PM EST. Meta Platforms' (META) stock closed at $716.50 after a remarkable 287.8% gain over three years. The company's aggressive investment in artificial intelligence and metaverse development has shaped investor expectations about its growth and risks. A Discounted Cash Flow (DCF) model projecting future cash flows estimates an intrinsic share value of $1,038.93, indicating the stock is currently about 31% undervalued. META's recent 3.1% annual return trails some peers, but its robust cash flow and anticipated expansion support its valuation. The price-to-earnings (P/E) metric and other traditional valuation techniques also provide insight into the market's view of Meta's future. Overall, despite strong recent performance, Meta Platforms still presents potential value for investors.
Go toTop